The Badminton World Federation (BWF) and the International Testing Agency (ITA) have formed a partnership that will see the management of all Therapeutic Use Exemptions (TUE) in badminton delegated to ITA’s specialized unit. With this collaboration, ITA will now have full responsibility for the TUE application process for all international-level athletes under BWF’s jurisdiction.
What are Therapeutic Use Exemptions (TUEs)?
TUEs are an essential component of an effective anti-doping program. Athletes who suffer from acute or chronic diseases or require specific therapy for their injuries may need to use a substance that is on the Prohibited List. In such cases, they must apply for a TUE to seek permission to use the prohibited substance for their medical condition and to have a valid justification if they test positive for it during a doping control.
Bạn đang xem: News | BWF Olympics
Xem thêm : News | BWF World Tour Finals
The approval process for TUEs involves a thorough examination by an expert body to determine the necessity of the exemption and prevent abuse. ITA’s specialized TUE department, along with its TUE Expert Group, will independently handle badminton’s TUE applications, reviews, and approvals in accordance with the World Anti-Doping Code and the International Standard for Therapeutic Use Exemptions.
BWF President Poul-Erik Høyer expressed his optimism about the partnership, stating, “This is a positive step forward for us in our endeavor to maintain the integrity of badminton. Having the leadership and expertise of the ITA to manage all TUE-related processes will enhance the robust testing measures we already have in place to safeguard our sport.”
Xem thêm : BWF Sudirman Cup 2017: Denmark Secures Quarter-Final Spot with Thrilling Victory
Benjamin Cohen, ITA Director General, also welcomed the collaboration, emphasizing ITA’s commitment to ensuring a fair and unbiased review of TUE submissions. He stated, “The delegation of TUE management to ITA provides assurance that BWF’s process will be handled professionally, and badminton athletes will receive the thorough evaluation they deserve. We look forward to fostering a wider partnership in the future.”
The initial term of the partnership will extend until the end of 2021.
FAQs
Q: What are Therapeutic Use Exemptions (TUEs)?
A: Therapeutic Use Exemptions allow athletes to use prohibited substances for legitimate medical purposes, provided they have obtained prior permission and can provide valid justifications if they test positive during doping control.
Q: Who will handle badminton’s TUE applications now?
A: ITA’s specialized TUE department, along with its TUE Expert Group, will independently handle the TUE application process, reviews, and approvals for badminton athletes.
Q: How long will the partnership between BWF and ITA last?
A: The partnership is set to run until the end of 2021.
Summary
The Badminton World Federation (BWF) has partnered with the International Testing Agency (ITA) to delegate the management of Therapeutic Use Exemptions (TUEs) in badminton to ITA’s specialized unit. This collaboration ensures that TUE applications from international-level athletes under BWF’s jurisdiction will be handled by ITA, independently and in accordance with anti-doping regulations. The aim is to maintain the integrity of the sport and protect athletes’ health while providing fair and unbiased evaluations of TUE submissions. BWF and ITA have expressed their confidence in this partnership, which will remain in effect until the end of 2021. For more information, visit Carnegiecentre.com.
Nguồn: https://carnegiecentre.com
Danh mục: Tin tức
